The Importance of Diagnosing Dry Eye Disease Early
Marguerite McDonald, MD
PeerDry Eye Disease Assessment and Treatment Plans
Christopher Starr, MD, FACS
PeerCarolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
PeerChallenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
PeerThe Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
Manish A. Shah, MD FASCO
PeerCarolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
PeerThe Clinical Use of HER2-Targeted Therapies in Gastric Cancer: The Current and Emerging Landscape
Manish A. Shah, MD FASCO
PeerMilton Packer, MD
PeerScreening for CKM syndrome
Jürgen Floege, MD
PeerShawna Nesbitt, MD
PeerEmerging Biomarker Landscape in Gastro/Gastroesophageal Cancer
Iacopo Olivotto, MD
PeerWhat do we know now that could have changed the history of CETP inhibition?: genetics and biology
John Kastelein, MD, PhD
PeerArtificial Intelligence in Medicine: 5 Key Issues Physicians Are Facing
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Hannah Lee, MD
Peer4 Ways AI Is Reshaping Healthcare’s Next Decade
Unveiling the Reperfusion Paradox
Manesh R. Patel, MD
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerA novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
PeerTailored to Fit: Precision Medicine in Metastatic CRC
Prioritizing LDL-C Reduction for Established CVD Patients in Primary Care
Clinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Kathleen Drinan, DO
PeerExpert Insights and Clinical Strategies for Postpartum Depression Screening
Screening for Postpartum Depression: A Guideline-Based Discussion